Figure 1 — TP53 somatic mutations are associated with poor survival in non-small cell lung cancer patients who undergo immunotherapy | Aging

Navigate

Submit an Article

Research Paper|Volume 12, Issue 14|pp. 14556–14568

TP53 somatic mutations are associated with poor survival in non-small cell lung cancer patients who undergo immunotherapy

Back to articleFigure 1(1 of 5)

100%

Figure 1.Flowchart of the study strategy.